PROMISE Substudy Results, Published in the American Heart Journal, Provide Independent Validation of the Clinical Value of the ...
REDWOOD CITY, CA--(Marketwired - Feb 6, 2017) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today the publication of a peer-reviewed substudy of the National Heart, Lung and Blood Institute (NHLBI)- …